Autologous and allogenic blood products for unanticipated massive blood loss in a Jehovah's witness

Anesthesia and Analgesia

Volumn 90, Issue 3, 2000, Pages 553-555

  Dasen, Kevin R ^a,b   Niswander, David G ^a   Schlenker, Richard E ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; INTRAOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RELIGION; SALPINGOOOPHORECTOMY; SURGICAL PATIENT; VAGINAL HYSTERECTOMY;

EID: 0034093209     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200003000-00010     Document Type: Article

References (23)

1. Testa LD, Tobias JD. Techniques of blood conservation. Am J Anesthesiol 1996;23:63-72.
2. Mann MC, Votto J, Kambe J, McNamee MJ. Management of the severely anemic patient who refuses transfusion: lessons learned during the care of a Jehovah's Witness. Ann Intern Med 1992;117:1042-8.
3. Malak J. Jehovah's Witnesses and medicine: an overview of beliefs and issues in their care. J Med Assoc Ga 1998;87:322-7.
4. Muramoto O. Recent developments in medical care of Jehovah's Witnesses. West J Med 1999;170:297-301.
5. Deleted in proof.
6. Muramoto O. Bioethics of the refusal of blood by Jehovah's Witnesses. Part 2. A novel approach based on rational non-interventional paternalism. J Med Ethics 1998;24:295-301.
7. Findley LJ, Redstone PM. Blood transfusion in adult Jehovah's Witnesses. Arch Intern Med 1982;142:606-7.
8. Vanelli P, Castelli P, Condemi AM, Santoli C. Blood saving in Jehovah's Witnesses. Ann Thorac Surg 1991;52:899-900.
9. Sazama K. Practical issues in informed consent for transfusion. Am J Clin Pathol 1997;107(4 Suppl 1):S72-4.
10. Goldman EB. Legal considerations for allogeneic blood transfusion. Am J Surg 1995;170(6A Suppl):27S-31S.
11. Blumenreich GA. Informed consent. AANA 1998;66:221-4.
12. Hartman KM, Liang BA. Exceptions to informed consent in emergency medicine. Hosp Physician 1999;35:53-60.
13. Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994;34:396-401.
14. Kunz J, Mahr R. Management of severe blood loss after tumor resection in a Jehovah's Witness. Gynakol Geburtshilfliche Rundsch 1995;35:34-7.
15. Atabek U, Spence RK, Pello M, et al. Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. Arch Surg 1992;127:349-51.
16. Lichtenstein A, Eckhart WF, Swanson KJ, et al. Unplanned intraoperative and postoperative hemodilution: oxygen transport and consumption during severe anemia. Anesthesiology 1988;69:119-22.
17. -1 with survival. Anaesth Intensive Care 1991;19:581-3.
18. Karn KE, Ogburn PL, Julian T, et al. Use of a whole blood substitute, Fluosol-DA 20%, after massive postpartum hemorrhage. Obstet Gynecol 1985;65:127-30.
19. Akingbola OA, Custer JR, Bunchman TE, Sedman AB. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 1994;22:524-8.
20. Zollinger A, Hager P, Singer T, et al. Extreme hemodilution due to massive blood loss in tumor surgery. Anesthesiology 1997; 87:985-7.
21. Fontana JL, Welborn L, Mongan PD, et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesth Analg 1995;80: 219-25.
22. Shibutani K, Komatsu T, Kubal K, et al. Critical level of oxygen delivery in anesthetized man. Crit Care Med 1983;11:640-3.
23. van Woerkens ECSM, Trouwborst A, van Lanschot JJB. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992;75:818-21.